Introduction {#sec1-1}
============

Oral facial clefts are congenital structural anomalies of the lip or palate that affects 1/1OOO\'s lives. The prevalence of orofacial clefts varies from 1/500 to 1/2500 births depending upon geographical origin, facial, ethnic backgrounds and socioeconomic status. These individuals after undergoing surgical repairs undergo speech, dental and sociological therapies. The aetiology of orofacial clefts is complex including multiple genetic and environmental factors. Thus the complex aetiology of clefts offers access to find the main cause such as genetic and environmental interactions, which alters the normal craniofacial development.

Facial Development {#sec1-2}
==================

Normal facial development begins with migrating mesial crest combining with mesoderm cells. These mesenchymal cells are being responsible for matured face and head. These cells are activated at spectrum of singling molecules, transcriptions and growth factors. Recently a group of genes like TGFA 1 (transforming growth factor Alpha 1), RARA (Retinoic Acid Receptor Alpha), TGFB (transforming growth factor Beta), MSX1 (Muscle segment homeo box 1), PAX1 (paired box 1), TGFA2 (transforming growth factor Alpha 2), PVRL 1 (Polio virus related 1) have been held responsible in the role of development of head particularly in development of lips and palate.\[[@ref1]--[@ref3]\]

Environmental Factors {#sec1-3}
=====================

Warkany (1943) 1^st^ reported that various nutritional deficiencies were responsible for cleft lip/palate.\[[@ref4]\] He recognized that teratogens such as Phenytoin, Valproic acid and Thalidomide were responsible for orofacial clefts.\[[@ref4]\] The other causes encountered are maternal alcohol drinking/cigarette smoking, involvement of pesticides such as Dioxin.\[[@ref5]\] Epidemiological studies for cleft lip/palate conducted till today in various parts of world indicated the involvement of environmental factors for clefts, especially in low economic status people. In Philippines a comparative study between people of high and low socio-economic status showed 1% of cleft lip/palate more in low socio economic group than in high socio group.\[[@ref6]\] Like-wise, frequencies of incidence were similar in other Asian group with same socio-economic status.\[[@ref7]\] A further increase in these geographical areas occurred whenever there was a history of maternal infections, smoking, alcohol consumptions and vitamin deficiencies during pregnancy.\[[@ref8][@ref9]\]

Genetics Vitamins and Congenital Factors {#sec1-4}
========================================

Orofacial clefts provide a unique genetic model for detail study. The genetic factors in clefting can be analyzed by various techniques including segregation analysis, additional genetic linkage etc.

Genetic linkage studies cleft lip/palate led to the specification of certain candidate genes situated in chromosomes 2, 4, 6, 17 and 19.\[[@ref10][@ref11]\] Studies from Denmark and Italy reported that loci on 6p have consistently shown linkage to cleft lip/palate.\[[@ref12]\] But such study has not been conducted in Indian race till recently. An epidemiological survey was been conducted for cleft lip/palate in and around Chennai population in 1962 and also in Calcutta in 2004. Finally, recent studies from different parts of world have shown the genes TGFA, 84S192, MSX1, TGFB3 and RARA as the most possible candidate gens for orofacial clefts.\[[@ref6][@ref7][@ref8][@ref13]--[@ref17]\]

In lieu the above evidences some studies have reported that vitamin deficiency, particularly vitamin A, leads to cleft lip/palate formation. Earlier, it was thought that consangual marriages might lead to cleft lip/palate formation. But a report in 2002 which was a comparative study of clefts with consangual and non-consangual families showed no significant difference in the incidence of clefts but, the low socio-economic status families of either group had more incidence of clefts.\[[@ref1][@ref9]--[@ref11][@ref17]\]

Animal Studies and Reports {#sec1-5}
==========================

Several animal studies have indicated similar features of gene expression as that of in humans. MSX1 gene is proved to be responsible for growth and development for earthworm.\[[@ref18]\] Recent studies on chimpanzee reported similar functions of TGF, MSX1, BMP genes as in human beings.\[[@ref18]\] Seven types of MSX1 gene found to be responsible for shape and development in Drosophila. Out of these, HOX/MSX7 are similar in function with respect to MSX1 of humans.\[[@ref19][@ref20]\]

Gene Environment Interaction {#sec1-6}
============================

Studies exploring the effect of environment factors on gene function leading to cleft lip/palate are relatively rare. Variation of TGFA expression due to smoking during pregnancy leading to cleft has been reported.\[[@ref17][@ref21]\] Vitamin A and its congeners Acutane are known to induce craniofacial anomalies possibly altering TGFB3 expression. Genetic involvement of cleft lip/palate formation due to folate deficiency remains controversial.\[[@ref18][@ref22]\]

Diagnosis and Prevention {#sec1-7}
========================

Even though the knowledge of interactions of gene and environmental factors are relatively less but still the detail history related to the interaction may be useful for better diagnosis and prevention of clefts.\[[@ref23]--[@ref25]\] Studies related to reduction in smoking and consumption of alcohol during pregnancy has shown to lower the risk of having the facial abnormality child.\[[@ref26]\] Drugs like anticonvulsant medications have been evaluated carefully and balanced against the risk of withdrawal for a mother affected with seizure disorder during pregnancy as the anticonvulsants are set to be teratogens leading to birth defects (cleft associate defect).\[[@ref27]--[@ref33]\] With respect to genetic diagnosis, a thorough counselling of any evidences like hypodontia/tooth agenesis and lip pits in pregnant mother should be advised to evaluate MSX1 gene mutations or to rule out any other known gene mutations and syndromes related to the findings. Finally, nutritional supplements such as folic acids, vitamin B6 and micronutrients provided to pregnant mother have proved to be responsible in good morphodifferentiation of the cells and their function provided the gene status is good.\[[@ref34]--[@ref37]\] In future, gene therapy may be the treatment of choice with proper evaluation, planning and with proper vectors and with target zones/genes in respect to treat the facial defects.\[[@ref38]--[@ref40]\]

In lieu the above literature, the present genetic study had been conducted to find out the possible alteration (mutation) of the MSX1 gene causing cleft/palate in South Indian population.

Materials and Methods {#sec1-8}
=====================

Eighty patients with non-syndromic CL/CLP/CP from various cleft operating centers in southern states (Karnataka, Tamilnadu, Kerala and Andhra Pradesh) with different ethnic/cultural background and 20 samples were collected from each state. The data collection was performed in accordance with individual ethical clearance from their cleft operating institute with the informed consent form signed by the patient and it was institutional based research. The DNA was extracted from the blood soaked blotting papers of the patients. Separate numbering was given for each collection zone.

DNA was extracted by standard Phenol/chloroform extraction protocol or disposable DNA extraction kits. The primers designed for Exon1 and Exon2 excluding the intron and UTR (untranslated region) were used for PCR amplification and then the amplified DNA samples were sequenced. To amplify protein binding sites the primers were designed with some modifications of previously published ones. The primer design as follows:

EXON1: Forward primer: 5'-CAT GCC CGG CGG CTG GCC AGT GCT-3'

Reverse primer: 5'-CTG CAG GTA CGC AGG CGC CGG AG-3'

EXON2: Forward primer: 5'-CGG CAC CGA GGC ACT TGG CGG CAC T-3'

Reverse primer: 5'-GAG CAC GTC CGG GGG TAC AGC ACC A-3'

Gene Information: GENE Muscle Segment Homeo Box1 \[[Figure 1](#F1){ref-type="fig"}\] {#sec1-9}
====================================================================================

![GENE MSX-l (Muscle segment homeo box gene 1)](IJHG-18-332-g001){#F1}

Gene sequence: Complete coding sequence (894 bp) {#sec2-1}
------------------------------------------------

ATGACTTCTTTGCCACTCGGTGTCAAAGTGGAG GACTCCGCCTTCGGCAAGCCGGCGGGGGGAGG CGCGGGCCAGGCCCCCAGCGCCGCCGCGGCCAC GGCAGCCGCCATGGGCGCGGACGAGGAGGGGGC CAAGCCCAAAGTGTCCCCTTCGCTCCTGCCCTTC AGCGTGGAGGCGCTCATGGCCGACCACAGGAAG CCGGGGGCCAAGGAGAGCGCCCTGGCGCCCTC CGAGGGCGTGCAGGCGGCGGGTGGCTCGGCGCA GCCACTGGGCGTCCCGCCGGGGTCGCTGGGA GCCCCGGACGCGCCCTCTTCGCCGCGGCCGCT CGGCCATTTCTCGGTGGGGGGACTCCTCAAGC TGCCAGAAGATGCGCTCGTCAAAGCCGAGAGC CCCGAGAAGCCCGAGAGGACCCCGTGGATGCA GAGCCCCCGCTTCTCCCCGCCGCCGGCCAGGC GGCTGAGCCCCCCAGCCTGCACCCTCCGCAAA CACAAGACGAACCGTAAGCCGCGGACGCCCTTC ACCACCGCGCAGCTGCTGGCGCTGGAGCGCAAG TTCCGCCAGAAGCAGTACCTGTCCATCGCCGAGC GCGCGGAGTTCTCCAGCTCGCTCAGCCTCACTG AGACGCAGGTGAAGATATGGTTCCAGAACCGCC GCGCCAAGGCAAAGAGACTACAAGAGGCAG AGCTGGAGAAGCTGAAGATGGCCGCCAAGCCCAT GCTGCCACCGGCTGCCTTCGGCCTCTCCTTC CCTCTCGGCGGCCCCGAGCTGTAGCGGCCGCGGC GGGTGCCTCGCTCTACGGTGCCTCTGGCCC CCAGCGCGCCGCGCTGCCTGTGG CGCCCGTGGGAC TCTACACGGCCCATGTGGG CTACAGCATGTA CCACCTGACATAG

Protein amino acid sequence for msx-l gene: (297 Amino acids) {#sec2-2}
-------------------------------------------------------------

MTSLPLGVKVEDSAFGKPAGGGAGQAPSAA AATAAAMGADEEGAKPKVSPSLLPFSVEALM ADHRKPGAKESALAPSEGVQAAGGSAQPLG VPPGSLGSLGAPDAPSSPRPLGHFSVGGLLKLPE DALVKAESPEKPERTPWMQSPRFSPPPARRLS PPACTLRKHKTNRKPRTPFTTAQLLALERKF RQYLSIAERAEFSSSLSLTETQVKIWFQN RRAKAKRLQEAELEKLKMAAKPMLPPAA FGLSFGLSFPLGGPAAVAAAAGASLYGA SGPFQRAALPVAPVGLYTAHVGYSMYHLT.

Exon 1 reference sequence: {#sec2-3}
--------------------------

(451 bp)ATGACTTCTTTGCCACTCGGTGTCA AAGTGGAGGACTCCGCCTTCGGCAAGCCGCG GGGGGAGGCGCGGGCCAGGC CCCCAGCGCCGCCGCGGCCACGGCAGCCGCCA TGGGCGCGGACGAGGAGGGGGC CAAGCCCAAAGTGTCCCCTTCGCTCCTGCCCTCA GCGTGGAGGCGCTCATGGCCGAC CACAGGAAGCCGGGGqCCAAGGAGAGCGCCC TGGCGCCCTCCGAGGGCGTGCAG GCGGCGGGTGGCTCGGCGCAGCCACTGGGCGT CCCGCCGGGGTCGCTGGGAGCCC CGGACGCGCCCTCTTCGCCGCGGCCGCCGGC CATTTCTCGGTGGGGGGACTCCTC AAGCTGCCAGAAGATGCGCTCGTCAAGCCGA GAGCCCCGAGAAGCCCGAGAGGA CCCCGTGGATGCAGAGCCCCCGCTTCTCCCCG CCGCCGGCCA

Exon 2 reference sequence {#sec2-4}
-------------------------

(443 bp) GGCGGCTGAGCCCCCCAG CCTGCACCCTCCGCAAACACAAGA CGAACCGTAAGCCGCGGACGCCC TTCACCACCGCGCAGCTGCTG GCGCTGGAGCGCAAGTTCCGCAGAA GCAGTACCTGTCCATCGCCGAGCGCGCG GAGTTCTCCAGCTCGCTCAGCCC ACTGAGACGCAGGTGAAGATATGGTTCCAGAA CCGCCGCGCCAAGGCAAAGAGA CTACAAGAGGCAGAGCTGGAGAAGCTGAAGAT GGCCGCCAAGCCCATGCTGCCA CCGGCTGCCTTCGGCCTCTCCTTCCCTCTCG GCGGCCCCGCAGCTGTAGCGGCC GCGGCGGGTGCCTCGCTCTACGGTGCCTCTG GCCCCTTCCAGCGCGCCGCGCTGCCTGTGG CGCCCGTGGGACTCTACACGGCCCATGTGGG CTACAGCATGTACCACCTGACATAG

Intron sequence (2326 bp) {#sec2-5}
-------------------------

GTGAGTAGCCAGAACCCAGGCGCAGAGGGAG GGGGCCGGGTGGGGGCCGGG TGGGGTGTGGGACCCGAGGGCTCCTGGTG GCCTCCGGCGCCTGCGTACCTGCAGC CGGTGCTAGGGAGCCGT GGGCTGCAAGGCCGG GTCTTGCGCCTCCCTCCACTCCC ACCCAGGAAGAAG GTTCCAGACCTCCTCGCCT TGGCCCAGAGACGCTGCGGGTGG GAGTTAACGGATAGGACACCGATGTCTGGGC ACCCTGTCCTCCTGCCCCCACCAA ACGACCTCAGGGGT CCATGATCCCTCATCTGA TCCCAAACTCTGTTTCATCGGCTT CACCCCAGCGGATGAATGTGTGTGGTGCGG TATCTTCCCTGCACCCGGAGTTTCA CTTTCTCGCAGTAGGAGCTGGTGTCCCCC AGCCCCTCTTCCCTTTCAAGTACCTCT TTGCCTAGAGGTTCCGAAGCTCCTACAGAAT TCTACCTCCCCATGCCCTTTGAGTT TGAGGCAGATAGTTGG TGCTTTGGGCGGAT GGATGATTCAGGGGTGGGGACATTC AGGTTCCAGTGGAGGGGGCGGGGCACC AAGTCAATTAGGGGAAGG CGCCCCCGC TAATCCTATGGGAA GCTCCCAAACGTCTA GGACTGAGCCATTAAAGTGGACTCCA GGTGCCCAAGGCGGTTCGCTCCAAGGCC TCACGGCCCCCTGGCTGCTCTACTCAG AGAACACGCTCGGAGAT ATTTCAGGAGCA CGGGAAATTCCCAAGTTTTCCTCGTT TCCTCCGATTATTTTGCTCGGCATAA TAGCAGCCAGATTTCAATG GCGTGATGCTG AGGAATGATTT TTATCTGGGGATTAAACGTCTTT GAAAGGCCAGTCCCTCCCTAA GCCTAATGGCC GGAGAAGGTGGCCCCGCTC TGGGTTGTCGCCGCTGAAGGGAGTG ACGTTTCTCTCGGCGCCCGCCCCTCGGGCGGCC CGGCGGAAAGCTAGTTGGGGGC CAAGCGCTTCCCGGACTCCCGGTGGCCTCC AGCAGGGAAGAAGCGGGGTGTTAA CACGAGATTTCGTTTGACTCACATCCT GGTGGTCTGAAAGTCCAA AGGATCGTTG TGTTTTCTTT GTTTTGTTTTGTTTTTTCTG TTTGTTTGTGGTTGTTTTTTAGAGAGGT GTGAAAAAATGCATACTTAGGCAAAACCC GCGTGGTGAAACATCTTCGATTTGAATT CACTTTCTGCCGGGAAAGCTGCTGCA TAGGCAAAGTGTCCTTTCCAACGCTTAG GGCCTTGGGCCCCAAGACCCCGAAGTCAA AGCGATCCCGGCTGTGTTGGGATAATTGA GGCAGATAGTTGGTGCTTTGGGCG GATGGATGATTCAGGGGTGGGGACATTC AGGTTCCAGTGGAGGGGGCGGGGCACC AAGTCAATTAGGGGAAGGCGCCCCCGC TAATCCTATGGGAAGCTCCCAAACGTCT AGGACTGAGCCATTAAAGTGGACTCCA GGTGCCCAAGGCGGTTCGCTCCAAGGCCTCAC GGCCCCCTGGC TGCTCTACTCAG AGAACACGC TCGGAGATATTTCAGGAGCA CGGGAAATTCCCAA GTTTTCCTCGTTTCCTCCGATTATTTTGC TCGGCATAATAGCAGCCAGATTTCAAT GGCGTGATGCTGAGGAATGATTTT TATCTGGGGATTAAACGTCTTTGAAAGGC CAGTCCCTCCCTAA GCCTAATGGCCGGA GAAGGTGGCCCCGCTCTGGGTTG TCGCCGCTGAAGGGAGTGACGTTTCTCTCG GCGCCCGCCCCTCGGGCGGCCCGGCG GAAAGCTAGTTGGGGGCCAAGCGCTTCCCGG ACTCCCGGTGGCCTCCAGCAGGGAA GAAGCGGGGTGTTAACACGAGATTTC GTTTGACTCACATCCTGGTGGTCTGAA AGTCCAAAGGATCGTTGTGTTTTCTTTGTTTT GTTTTGTTTTTTCTGTTTGTTTGTGG TTGTTTTTTAGAGAGGTGTGAAAAAAT GCATACTTAGGCAAAACCCGCGTGGTGAA ACATCTTCGATTTGAATTCACTTTCTGCCG GGAAAGCTGCTGCATAGGCAAAGTGTC CTTTCCAACGCTTAGGGCCTTGGGCC CCAAGACCCCGAAGTCAAAGCGATCCCGG CTGTGTTGGGATAAT

PCR {#sec2-6}
---

The PCR was performed for 35 cycles in 100 μl and the mater mix composition is as follows:

DNA: 100 ng

dNTP mix (2.5 mM each): 4.0 μl

Forward Primer: 400 ng

Reverse Primer: 400 ng

Hot-start Taq polymerase assay buffer (10X): 1X

Hot-start Taq polymerase Enzyme: 5U

Glass distilled water was added to make up the volume to 100 μl

Sequencing {#sec2-7}
----------

The PCR product was detected on a 1.5% agarose gel and then extracted from agarose by DNA extraction kit for sequencing.

ABI applied Bio-system incorporated sequencing kit was used for sequencing reaction and data was analyzed on genetic analyzer model no ABI3100.

The results were compared to the published sequence Nr. AF 426432 in NCBI database \[[Table 1](#T1){ref-type="table"}\].

###### 

Muscle segment homeo box1 gene analysis for exon 1

![](IJHG-18-332-g002)

Results and Discussion {#sec1-10}
======================

Twenty cleft samples from the natives of each state where been studied for genetic analysis. Analysis of exon 1 of MSX1 of samples from different states reveals that except for Andhra Pradesh, more than one single point mutation was found in other states. Moreover, out of these mutations noticed, one of them was a silent mutation (C330T). Finally the result indicated that the cleft samples so collected from Andhra Pradesh had only one point mutation of G to A/C at 273 positions. The importance of this mutation site is further substantiated by the fact that all the samples obtained from the states of Karnataka and Kerala also had the same. However this mutation was not noticed in the samples from Tamilnadu instead a silent mutation at C330T, and point mutation at C102G was noticed. Interestingly, this mutation was also noticed in the samples of Karnataka and Kerala. Therefore, analysis of [Table 1](#T1){ref-type="table"} indicates that mutation of either G273A/C or C102G seems to be quite important for cleft formation and the mutation of G273A/C and C102G as lead to the change of either an acidic amino acid aspartic acid or a bulky, basic amino acid, arginine form a neutral, small amino acid, glycine is clear. So change in amino acid from a small, neutral one to a bulky, charged would have lead to a significant change in the conformation of the protein resulting in a functionally different protein.

In this analysis we also found a novel mutation (414G to T) which is submitted to NCBI Gene data bank (EF065625). We found less data in relation to Andhra zone for MSX1 whereas a good data was available in Kerala. We also noticed some samples produced insignificant sequence due to rich GC content of the gene.

Summary: In this analysis, we also found a novel mutation (414G to T) which is submitted to NCBI Gene data bank (EF065625). We found less data in relation to Andhra zone for MSX1 whereas a good data was available in Kerala. We also noticed some samples produced insignificant sequence due to rich GC content of the gene.

In case of exon 2, though some studies have shown change in amino acid from arginine to serine in position 151 and silent mutations at positions 181 and 275 but in our study we had no significant findings in exon 2.\[[@ref29]\]

Conclusion {#sec1-11}
==========

In comparison to the previous gene sequence Nr. AF426432 data (NCBI) this research article projects similar reports and positively reflects the genetic implications in South Indian population for MSX1 gene. In spite of multiple cultural/ethnic backgrounds genetic variations were similar in comparison to previous reports. We feel that this study may be the stepping stone for prenatal investigations/counseling and genetic correction through genetic engineering in future days to come for oral clefts.
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